The first-line treatment for chronic aplastic anemia is

The first-line treatment for chronic aplastic anemia involves androgen medications, such as testosterone propionate. These drugs work by promoting hematopoietic function, but their effects are relatively slow. Typically, therapeutic benefits become evident only after two to three months of medication, and the treatment course should last for more than six months. Commonly used androgens include testosterone propionate, stanozolol (Kanglilong), mesterolone (An雄), and danazol. Although the condition of most patients can achieve remission, a portion of patients still experience persistent illness, and cases achieving complete recovery are rare. Treatment of chronic aplastic anemia also requires individualized approaches based on the patient's specific condition, incorporating other therapies such as surgical splenectomy and traditional Chinese medicine.